Wolfgang Nickl

Wolfgang Nickl serves as Chief Financial Officer and member of the Board of Management at Bayer AG, one of the world's leading life sciences companies. Born in Hechingen, Germany, on May 9, 1969, Nickl has established himself as a transformational finance leader with over three decades of international experience across technology, semiconductor, and pharmaceutical industries. He joined Bayer in April 2018, shortly before the completion of the company's transformative $66 billion Monsanto acquisition, bringing critical expertise to navigate one of the largest mergers in corporate history. As CFO, Nickl oversees global financial operations for a company with annual revenues exceeding €47 billion and is responsible for the North American region. His leadership has been instrumental during a challenging period that included extensive litigation related to the Monsanto acquisition and significant debt management. Nickl has championed Bayer's strategic transformation, including the implementation of Dynamic Shared Ownership, a decentralized management approach designed to empower employees and accelerate decision-making. His financial stewardship focuses on building strong cash-flow discipline, leveraging artificial intelligence, and driving digitalization initiatives across the organization. Prior to Bayer, Nickl served as Executive Vice President and CFO at ASML N.V., the world's leading supplier of lithography systems for the semiconductor industry, where he managed financial operations for cutting-edge technology development. His earlier tenure as CFO at Western Digital Corporation demonstrated his ability to lead financial strategy for major technology companies in highly competitive markets. Known for his strategic vision and operational excellence, Nickl combines deep financial acumen with extensive international business experience, making him a trusted advisor in boardrooms and a respected voice in the global pharmaceutical industry.